Most people on semaglutide lose about 3.8% of their body weight in the first month, with losses accelerating over the following months. By 68 weeks, participants in the landmark STEP 1 clinical trial lost an average of 14.9% of their starting weight, compared to just 2.4% for those on a placebo. For someone starting at 250 pounds, that works out to roughly 37 pounds over about 16 months.
What to Expect Month by Month
Weight loss on semaglutide follows a predictable curve: slow at first, then faster as the dose increases, then gradually leveling off. The STEP 1 trial, which tested the 2.4 mg weekly injection in over 1,900 adults, mapped this trajectory clearly.
At 4 weeks, average weight loss was 3.8% of baseline body weight. That’s roughly 9.5 pounds for someone starting at 250. This early phase coincides with the lowest dose, so results are modest. By 12 weeks (3 months), participants had lost an average of 9.6% of their starting weight. That same 250-pound person would be down about 24 pounds. At 6 months, the average reached 13.8%, or about 34.5 pounds on a 250-pound frame. The final result at 68 weeks was 14.9%, meaning most of the weight loss happened in the first six months, with continued but slower progress after that.
Weight loss tends to plateau around 60 weeks. After that point, most people stabilize at their new weight rather than continuing to lose. This isn’t a failure of the medication. It reflects your body reaching a new equilibrium between reduced calorie intake and metabolic adaptation.
Why the First Weeks Feel Slow
Semaglutide starts at a low dose of 0.25 mg per week and increases every four weeks. This gradual ramp-up, called titration, exists to reduce side effects like nausea, which are more likely if you jump straight to the full dose. It takes about 16 to 20 weeks to reach the maintenance dose of 2.4 mg per week.
Because of this, the medication isn’t working at full strength during the first several months. The weight loss you see at 4 weeks reflects a fraction of the drug’s potential. If your early results feel underwhelming, that’s expected. The steepest losses typically happen between months 2 and 6, once you’re on higher doses.
How Semaglutide Reduces Weight
Semaglutide mimics a gut hormone called GLP-1 that your body naturally produces after eating. This hormone activates receptors in the brain’s hunger-control centers, dialing down appetite and reducing cravings. The effect is often dramatic: many people describe simply not thinking about food as much, or feeling satisfied after portions that previously wouldn’t have been enough.
The drug also slows the rate at which food leaves your stomach. This creates a prolonged feeling of fullness after meals, which naturally leads to eating less throughout the day. The combination of reduced hunger signals from the brain and slower digestion from the gut is what drives the calorie deficit responsible for weight loss. You’re not burning more calories. You’re consuming fewer of them, often without feeling deprived.
Diabetes Changes the Numbers
If you have type 2 diabetes, expect somewhat lower weight loss than the headline numbers suggest. In clinical trials, people without diabetes lost an average of 14.9% of their body weight over 68 weeks, while those with type 2 diabetes lost about 9.6% in the same timeframe. That’s still significant, but it’s roughly a third less.
Several factors explain this gap. Insulin resistance, which is central to type 2 diabetes, makes the body more resistant to weight loss in general. Some diabetes medications can also promote weight gain, partially offsetting semaglutide’s effects. And the metabolic changes that come with long-standing blood sugar problems can slow the body’s response to appetite-based interventions. If you have diabetes, 9 to 10% weight loss is a realistic target rather than the 15% often cited.
Individual Results Vary Widely
The averages from clinical trials are useful benchmarks, but individual responses to semaglutide cover a wide range. In the STEP 1 trial, 86.4% of people on semaglutide lost at least 5% of their body weight, which means roughly 1 in 7 didn’t reach even that threshold. Some people lose 20% or more, while others lose single digits.
Several factors influence where you land on that spectrum. Starting weight, age, metabolic health, diet, physical activity, sleep quality, and stress levels all play a role. People who combine semaglutide with structured lifestyle changes (consistent exercise, higher protein intake, reduced processed food) generally lose more than those who rely on the medication alone. The drug reduces appetite, but what you eat when you do eat still matters for both the speed and sustainability of results.
What Happens After the Plateau
Once weight loss levels off around 60 weeks, you’re in the maintenance phase. Clinical data shows that stopping semaglutide leads to significant weight regain in most people, because the appetite suppression and slowed digestion only last while the drug is active. This is why semaglutide is generally considered a long-term medication rather than a short course.
Staying on the maintenance dose keeps the weight off for most people. The decision about how long to continue involves weighing the ongoing cost, side effects, and your personal health goals. Some people use the weight loss window to build exercise habits and dietary patterns that help them maintain a lower weight if they eventually stop, though regain of at least some weight is common.